Drug Approval | September 30, 2023
Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 manufacturing facility
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Commenced operations in flood-affected Himachal Pradesh
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Subscribe To Our Newsletter & Stay Updated
